Therapie 2008 Jan-Feb;63(1):67-8
Dig Dis Sci 1994 Jul;39(7):1389-94
Istituto di Fisiopatologia Medica e Medicina Nucleare, Università G. D'Annunzio, Chieti, Italy.
The effect of cimetropium bromide, a new anticholinergic agent, in patients with primary achalasia was studied. Twenty such patients (12 females and 8 males, mean age 38 years, range 15-56) were studied. Diagnosis was performed by radiology, endoscopy, and manometry. Read More